Introduction
Although advance in diagnostic and therapeutic aspects has improved the prognosis of the patients with esophageal carcinoma, it is often wide-spread at the time of detection, and the prognosisof patients, especially with far advanced tumor infiltrating neighboring structures (T4), is still quite unfavorable1,2).
Combined surgery and preoperative hyperthermia combined with chemotherapy and irradiation has been performed for T4 esophageal carcinoma and contributed the improvement of prognosis of the patients3-5).
Although tumor invasion through the wall of the esophagus is the factor determining the postoperative prognosis°, the predictive factor on the prognosis of patients with T4 esophageal carcinoma has not been established.
In the current study, clinicopathological features of patients who survived over 5 years after surgical treatment for T4 esophageal carcinoma were investigated.
Patients and Methods

Patients with T4 esophageal carcinoma
Consecutive 132 patients with esophageal carcinoma invading to neighboring structures (T4) , who had been treated with esophageal resection and reconstruction from 1965 to 2000 in our institute , were studied. The patients who have been surviving within 5 years after operation and who died of other disease were excluded in the current study.
Preoperative therapy
One hundred and eleven patients underwent a preoperative therapy, including 40 patients treated with hyperthermo-chemo-radiotherapy, 32 with chemo-radiotherapy , 33 with radiotherapy alone, and 6 with chemotherapy alone. At the beginning, chemotherapy was performed with intravenous administation of 5 mg of bleomycin twice a week and for three weeks (total of 30 mg) . Since 1990, 50 mgper week of cisplatin were administered intravenously and for three weeks (total of 150 mg) . 2 Gy per day of radiotherapy was given for 5 days per week and for 3 weeks (total of 30 Gy).
Hyperthermia was performed using radiofrequency system with an endotract electrode (Endoradiotherm 100A, 200A, Olympus, Tokyo, Japan), with the procedure described previously'-12>. For patients treated with hyperthermo-chemo-radiotherapy, the chemotherapy and hyperthermia were simultaneously performed after radiotherapy.
The effectiveness of the preoperative therapy was determined by the guidelines for clinical and pathologic studies on carcinoma of the esophagus established by the Japanese Society for Esophageal Diseases13) (Table I. ).
Statistical analysis
The chi-square test and Mann-Whitney test were used to compare the clinicopathological data . The cumulative survival rates were calculated by the Kaplan-Meier method and the survival curves were tested by the Mantel-Cox method. A p value of less than 0.05 was regarded as significant . 
Results
Overall 1-, 3-, and 5-year survival rates were 40.1%, 10.5% and 7.9%, respectively ( Fig.1) . One hundred and twenty-one patients died of carcinoma within 5 years after operation (Group D) and 11 have been alive more than 5 years without any recurrence of the tumor (Group A). The clinicopathological features were compared between these groups. Although no significant difference was observed regarding the variation of organs being affected by esophageal carcinoma, the proportion of patients with carcinoma invasion to plural organs was higher in Group D than that in Group A (Table II. ). The clinicopathological characteristics are shown in Table III . Although there was no significant difference regarding gender, the mean age in Group A (56.9±9.4) was significantly lower than that in Group D (62.8±8.9 ; p=0.0375). And there was no significant difference in locations and the pathological types of the tumors.
Although there was no significant difference, the mean length of the tumors in Group A (8.4±2.6 cm) was rather larger than that (7.0±2.2 cm) in Group D.
Regarding the proportions of lymph node metastasis and venous invasion, there was no significant difference between two groups. However proportion of lymphatic invasion in Group A (0%) was significant lower than that in Group D (52.9%, 64 out of 121 ; p=0.0008).
Three of 10 (30%) in Group A and 7 of 101 (6.9%) in Group D acquired marked effectiveness after preoperative therapy and there was a significant difference between these values (p=0.0341). The preoperative therapy and the effect brought by the therapy were shown in Table N . All of the 3 patients having marked effectiveness were treated with preoperative hyperthermo-chemo-radiotherapy . 
Discussion
Surgical treatment for esophageal carcinoma invading to neighboring structures (T4) is definedas non-curative operation according to guidelines for clinical and pathologic studies on carcinoma of the esophagus established by the Japanese Society for Esophageal Diseases13).
Although preoperative therapy has contributed to the improvement of prognosis of the patients with T4 esophageal carcinomas) 14) , five year survival rate has been reported as at most 20% 15) Some previous reports emphasized that surgical treatment alone could not contribute to the improvement of the prognosis of patients with T4 esophageal carcinoma'6) 17). Fockens et al.17) reported that there was no significant difference of the prognosis between patients with T4 esophageal carcinoma whose tumors were resected and patients who were surgically explored and that there was no 5-year survivor among the patients who were surgically treated.
On the other hands, there have been some reports regarding the predictive indicator for the effectiveness of the preoperative therapy for esophageal carcinoma" [18] [19] [20] [21] [22] . And some previous reportsemphasized that the patients with esophageal carcinoma with marked effectiveness for the preoperative therapy could acquire a more favorable prognosis after surgical treatment4) 5) 12) 15) 23). Furthermore it has been emphasized that surgical treatment has a chief role in the multimodal treatment for patient with esophageal carcinoma24) because microscopic tumor had been detected in the resected specimen even if the effectiveness was acquired by preoperative therapy.
And some previous reports suggested that more aggressive multimodal protocol may be indicated for patients with esophageal carcinoma invading to the neighboring structures because of the frequent recurrence of the tumor after surgical treatment25-27).
The proportion of acquirement in marked effect of preoperative therapy was significantly higher in five year survivors, and all of the three patients who acquired marked effect were treated with preoperative hyperthermia combined with chemotherapy and radiotherapy. The proportion of lymphatic invasionin 5-year survivors is significantly lower, which was likely to be derived from the excellent effect brought by the preoperative therapy. These findings may suggest that preoperative hyperthermo-chemoradiotherapy could contribute to the improvement of the prognosis of patients with far advanced esophageal carcinoma invading neighboring structures.
In conclusion, although the surgical treatment still has a chief role to treat the patients with esophageal carcinoma, preoperative hyperthermia combined with chemotherapy and irradiation can contribute to the improvement of prognosis in patients with T4 esophageal carcinoma. 
